A common blood pressure drug may help a major class of cancer therapies work far better than expected. A widely prescribed blood pressure drug may have an unexpected second life as a cancer therapy booster. Researchers at Dartmouth Cancer Center (DCC) have discovered that telmisartan, an FDA-approved medication commonly used to treat hypertension, can significantly [...]